Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × Platinum Compounds × 90 days × Clear all

Phase

Status

Recruiting 8 Not yet recruiting 5 Active not recruiting 2 Terminated 1 Enrolling by invitation 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 1

Interventions

pembrolizumab 34 Nivolumab 12 Carboplatin 10 venetoclax 9 Specimen Handling 9 Biopsy 9 Gemcitabine 8 fludarabine 7 atezolizumab 7 Radiosurgery 7 Pemetrexed 7 Magnetic Resonance Spectroscopy 7 Azacitidine 7 olaparib 6 durvalumab 6 Surveys and Questionnaires 6 Paclitaxel 6 Docetaxel 6 Cyclophosphamide 6 Trastuzumab 5 Interviews as Topic 5 Fulvestrant 5 Drug Therapy 5 tislelizumab 4 binimetinib 4 X-Rays 4 Radiotherapy 4 Radiation 4 Ipilimumab 4 Injections 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04966676 2026-01-08

ATLAS

University Health Network, Toronto

Phase 2 Terminated

Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon ⚡